Plenary speakers

PLENARY LECTURES

The personal story of a chemical engineer who spent most of his research life in the field of hydrodynamics of multiphase chemical reactors, chaired the European Federation of Chemical Engineering and the Czech Academy of Sciences, ran for president of the Czech Republic, and currently serves as the Chair of the Committee on Education, Science and Culture of the Czech Senate. The presentation looks at how an engineering background helps making good decisions for the society.
___________________

___________________

The global pandemic has impacted supply chains across every single sector of the economy, and it certainly impacted the pharmaceutical industry both the commercial manufacturing and supply of medicines as well as Research and Development of new medicines, including the challenging need for accelerated development of new vaccines and therapeutics for Covid-19. Being able to respond to such multidimensional challenges instigated numerous innovative approaches, with new ways of working in laboratories and manufacturing plants implemented almost overnight, and many tools and technologies being rapidly deployed. Technology solutions implemented in process development, scale up, manufacturing, packaging, labelling and distribution of medicines embraced since last year will no doubt contribute to further digitalisation and optimisation across all the nodes in the clinical supply chain. Some examples of these approaches and technologies and how they have been used to ensure critical drug development and supply continued and new trials were enabled through the pandemic will be presented..
___________________

The chemical industry has a vital role to play in the climate discussion. On the one hand, chemical products are essential to many low-carbon technologies. On the other hand, chemical production is energy and CO₂-intensive and the processes have been optimized for many decades. Therefore, BASF has launched a comprehensive Carbon Management Program and pursues a multi-pronged approach to cut its emissions significantly. The challenges and opportunities of this transformation will be presented and discussed.

___________________

as confirmed in December 20

The global pandemic has impacted supply chains across every single sector of the economy, and it certainly impacted the pharmaceutical industry both the commercial manufacturing and supply of medicines as well as Research and Development of new medicines, including the challenging need for accelerated development of new vaccines and therapeutics for Covid-19. Being able to respond to such multidimensional challenges instigated numerous innovative approaches, with new ways of working in laboratories and manufacturing plants implemented almost overnight, and many tools and technologies being rapidly deployed. Technology solutions implemented in process development, scale up, manufacturing, packaging, labelling and distribution of medicines embraced since last year will no doubt contribute to further digitalisation and optimisation across all the nodes in the clinical supply chain. Some examples of these approaches and technologies and how they have been used to ensure critical drug development and supply continued and new trials were enabled through the pandemic will be presented.

Organiser and Contact

#ecceecab21